Brokerages expect that Henry Schein, Inc. (NASDAQ:HSIC) will report earnings of $0.86 per share for the current quarter, according to Zacks. Seven analysts have provided estimates for Henry Schein’s earnings, with the lowest EPS estimate coming in at $0.85 and the highest estimate coming in at $0.88. Henry Schein reported earnings per share of $1.03 during the same quarter last year, which would suggest a negative year over year growth rate of 16.5%. The firm is scheduled to announce its next earnings results on Tuesday, November 5th.
According to Zacks, analysts expect that Henry Schein will report full-year earnings of $3.46 per share for the current fiscal year, with EPS estimates ranging from $3.44 to $3.48. For the next year, analysts expect that the business will post earnings of $3.75 per share, with EPS estimates ranging from $3.66 to $3.80. Zacks’ earnings per share calculations are a mean average based on a survey of analysts that follow Henry Schein.
Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, August 6th. The company reported $0.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.83 by $0.01. The company had revenue of $2.45 billion for the quarter, compared to the consensus estimate of $2.48 billion. Henry Schein had a net margin of 4.18% and a return on equity of 16.67%. The company’s revenue was up 5.7% compared to the same quarter last year. During the same period in the prior year, the company posted $1.04 EPS.
A number of research firms have issued reports on HSIC. Zacks Investment Research cut Henry Schein from a “buy” rating to a “hold” rating and set a $76.00 target price on the stock. in a research report on Wednesday, June 19th. BidaskClub cut Henry Schein from a “hold” rating to a “sell” rating in a report on Wednesday, July 24th. Cleveland Research restated a “hold” rating on shares of Henry Schein in a report on Thursday, May 2nd. Barrington Research restated a “buy” rating and set a $75.00 price target on shares of Henry Schein in a report on Wednesday, August 7th. Finally, William Blair cut Henry Schein from an “outperform” rating to a “market perform” rating in a report on Wednesday, August 7th. Seven equities research analysts have rated the stock with a sell rating, nine have given a hold rating and four have given a buy rating to the company. Henry Schein has an average rating of “Hold” and an average price target of $73.64.
HSIC opened at $61.54 on Tuesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.95 and a current ratio of 1.70. Henry Schein has a fifty-two week low of $56.58 and a fifty-two week high of $72.81. The company has a market capitalization of $9.23 billion, a P/E ratio of 14.90, a P/E/G ratio of 2.45 and a beta of 0.84. The stock has a fifty day moving average of $67.25 and a 200-day moving average of $65.20.
In other Henry Schein news, Director E Dianne Rekow sold 3,500 shares of the business’s stock in a transaction that occurred on Friday, June 14th. The stock was sold at an average price of $71.18, for a total value of $249,130.00. Following the transaction, the director now directly owns 14,147 shares of the company’s stock, valued at $1,006,983.46. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Paul Brons sold 1,758 shares of the business’s stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $70.96, for a total value of $124,747.68. Following the completion of the transaction, the director now directly owns 17,582 shares in the company, valued at $1,247,618.72. The disclosure for this sale can be found here. Over the last three months, insiders sold 56,524 shares of company stock worth $3,984,949. Insiders own 1.06% of the company’s stock.
Institutional investors and hedge funds have recently modified their holdings of the business. Cullen Frost Bankers Inc. bought a new position in Henry Schein in the 2nd quarter valued at $36,000. CSat Investment Advisory L.P. grew its stake in Henry Schein by 115.6% in the 1st quarter. CSat Investment Advisory L.P. now owns 552 shares of the company’s stock valued at $33,000 after purchasing an additional 296 shares during the period. Ibex Wealth Advisors bought a new position in Henry Schein in the 2nd quarter valued at $40,000. Parallel Advisors LLC grew its stake in Henry Schein by 67.4% in the 1st quarter. Parallel Advisors LLC now owns 586 shares of the company’s stock valued at $35,000 after purchasing an additional 236 shares during the period. Finally, First Hawaiian Bank grew its stake in Henry Schein by 66.7% in the 1st quarter. First Hawaiian Bank now owns 650 shares of the company’s stock valued at $39,000 after purchasing an additional 260 shares during the period.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More: Systematic Risk and Investors
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.